Literature DB >> 16967283

Prognostic significance of microalbuminuria in postdiarrheal hemolytic uremic syndrome.

Randall Lou-Meda1, Robert S Oakes, Jarom N Gilstrap, Christopher G Williams, Richard L Siegler.   

Abstract

Patients who survive the acute phase of postdiarrheal hemolytic uremic syndrome (D+ HUS) may develop renal complications after years of apparent recovery. The optimal regimen for monitoring these children is unclear. We therefore determined if screening for microalbuminuria, in the absence of overt proteinuria at follow-up, increased the sensitivity for predicting long-term renal-related sequelae. We found that screening for microalbuminurea, within the first 6-18 months following an episode of HUS, increased the sensitivity for predicting later sequelae from 22 to 66.7%, compared to screening for overt proteinuria alone. These findings, if confirmed by a larger cohort with more years of follow-up, may facilitate early initiation of intervention strategies designed to reduce progressive renal damage.

Entities:  

Mesh:

Year:  2006        PMID: 16967283     DOI: 10.1007/s00467-006-0283-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow.

Authors:  D Hüseman; J Gellermann; I Vollmer; I Ohde; S Devaux; J H Ehrich; G Filler
Journal:  Pediatr Nephrol       Date:  1999-10       Impact factor: 3.714

2.  The hemolytic-uremic syndrome.

Authors:  C A Gianantonio; M Vitacco; F Mendilaharzu; G E Gallo; E T Sojo
Journal:  Nephron       Date:  1973       Impact factor: 2.847

3.  Hemolytic uremic syndrome in childhood: renal function ten years later.

Authors:  M Van Dyck; W Proesmans; M Depraetere
Journal:  Clin Nephrol       Date:  1988-03       Impact factor: 0.975

4.  Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features.

Authors:  C Loirat; E Sonsino; A Varga Moreno; G Pillion; J C Mercier; F Beaufils; H Mathieu
Journal:  Acta Paediatr Scand       Date:  1984-07

Review 5.  Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?

Authors:  Karl F Hilgers; Jörg Dötsch; Wolfgang Rascher; Johannes F E Mann
Journal:  Pediatr Nephrol       Date:  2004-07-22       Impact factor: 3.714

6.  Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.

Authors:  M F Gagnadoux; R Habib; M C Gubler; J L Bacri; M Broyer
Journal:  Clin Nephrol       Date:  1996-07       Impact factor: 0.975

7.  Childhood haemolytic uraemic syndrome: long-term outcome and prognostic features.

Authors:  A Kelles; M Van Dyck; W Proesmans
Journal:  Eur J Pediatr       Date:  1994-01       Impact factor: 3.183

8.  Long term renal outcome of childhood haemolytic uraemic syndrome.

Authors:  M M Fitzpatrick; V Shah; R S Trompeter; M J Dillon; T M Barratt
Journal:  BMJ       Date:  1991-08-31

9.  Variability of urine albumin excretion in normal and diabetic children.

Authors:  D M Gibb; V Shah; M Preece; T M Barratt
Journal:  Pediatr Nephrol       Date:  1989-10       Impact factor: 3.714

10.  Urine microalbumin/creatinine ratios in Singapore children.

Authors:  C Yap; H K Yap; L F Chio
Journal:  J Singapore Paediatr Soc       Date:  1991
View more
  7 in total

1.  Introduction: education teaching article series on hemolytic uremic syndrome.

Authors:  Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2008-06-06       Impact factor: 3.714

2.  Levels of urinary transforming growth factor beta-1 in children with D+ hemolytic uremic syndrome.

Authors:  María Gracia Caletti; Alejandro Balestracci; Adriana Haydeé Roy
Journal:  Pediatr Nephrol       Date:  2010-02-16       Impact factor: 3.714

Review 3.  HUS and TTP in Children.

Authors:  Howard Trachtman
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

4.  Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis.

Authors:  Carlos J Cobeñas; Laura F Alconcher; Ana P Spizzirri; Ricardo C Rahman
Journal:  Pediatr Nephrol       Date:  2007-06-13       Impact factor: 3.714

Review 5.  Proteinuria and progression of glomerular diseases.

Authors:  Elif Erkan
Journal:  Pediatr Nephrol       Date:  2012-11-03       Impact factor: 3.714

Review 6.  Hemolytic uremic syndrome: toxins, vessels, and inflammation.

Authors:  Victoria Cheung; Howard Trachtman
Journal:  Front Med (Lausanne)       Date:  2014-11-04

7.  Hemolytic uremic syndrome: late renal injury and changing incidence-a single centre experience in Canada.

Authors:  Pierre Robitaille; Marie-José Clermont; Aïcha Mérouani; Véronique Phan; Anne-Laure Lapeyraque
Journal:  Scientifica (Cairo)       Date:  2012-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.